Geoff Meacham
Stock Analyst at Citigroup
(2.31)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AMGN Amgen | Maintains: Neutral | 305 310 | 285.1 | 8.73% | 13 | Aug 6, 2025 | |
BIIB Biogen | Maintains: Neutral | 125 135 | 128.03 | 5.44% | 15 | Aug 1, 2025 | |
PTCT PTC Therapeutics | Maintains: Neutral | 40 50 | 43.3 | 15.47% | 9 | Jul 28, 2025 | |
CRSP CRISPR Therapeutics | Maintains: Buy | 79 78 | 55.44 | 40.69% | 3 | Jul 22, 2025 | |
RPRX Royalty Pharma | Maintains: Strong Buy | 40 42 | 36.2 | 16.02% | 3 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 50 54 | 48.24 | 11.94% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 72 | 53.77 | 33.9% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 42 | 24.4 | 72.13% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 110 | 69.11 | 59.17% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 7.81 | 53.65% | 2 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 4 | 1.41 | 183.69% | 4 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 6 | 8.04 | -25.37% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 70 75 | 45.74 | 63.97% | 6 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 700 650 | 546.18 | 19.01% | 10 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 210 205 | 198.62 | 3.21% | 17 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 47 44 | 37.69 | 16.74% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 145 140 | 109.29 | 28.1% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 7 1 | 1.44 | -30.56% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 40 | 25.48 | 56.99% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 32.74 | 22.17% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 95 | 34.58 | 174.73% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 8.76 | 185.39% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 99 103 | 56.8 | 81.34% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 112 4 | 6.36 | -37.11% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 125 | 120.57 | 3.67% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 575 | 374.47 | 53.55% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1150 1100 | 635.48 | 73.1% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 120 20 | 10.56 | 89.39% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 22 31 | 10.1 | 206.93% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 10 | n/a | n/a | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 150 145 | 80.06 | 81.11% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 180 170 | 173.87 | -2.23% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 24 48 | 22.68 | 111.64% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 5 3 | n/a | n/a | 1 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 68 60 | 45.94 | 30.61% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 8 | 1.28 | 525% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 14 | 4.28 | 227.1% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 10 8 | 5.42 | 47.6% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 17 | 0.5 | 3300% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 17 14 | 19 | -26.32% | 5 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 45 | 24.61 | 82.85% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 21 14 | 3.18 | 340.25% | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 24 | 1.45 | 1555.17% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 12 4 | 4.13 | -3.15% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | n/a | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 7 | 10.5 | -33.33% | 2 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | 1.48 | 1791.89% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | 0.49 | 6838.78% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 56 56 | 8.52 | 557.28% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 | 1.85 | 1791.89% | 4 | Jan 15, 2021 |